Brief description: The Specialty Network Infectious Diseases (SNID) supports infectious disease studies and strengthens the clinical research landscape in Germany. As the first specialty network within the NUM Study Network, it builds on the structures of NAPKON and NUKLEUS.
Role of NUM-MB: SOP manuals for biological samples, training materials and training courses on biological samples, biological samples helpdesk, support with data integration into NUKLEUS-LIMS, definition of quality levels for biological samples, release of biological samples
Brief description: The Speciality Network for Critical Care (SN CritCare) is a specialty network within the NUM Study Network and aims to establish a high-performing, nationwide network of university study centres that will sustainably strengthen clinical research into critically ill patients with acute organ dysfunction.
Role of NUM-MB: SOP manuals for biological samples, training materials and courses on biological samples, biological samples helpdesk, support with data integration into NUKLEUS-LIMS, dispensing of biological samples
Brief description: The establishment of the interdisciplinary Speciality Network Stroke (SN Stroke) offers a unique opportunity to build a nationwide infrastructure for transformative, large-scale clinical trials in the field of stroke prevention and treatment.
Role of NUM-MB: SOP manuals for biological samples, training materials and training courses on biological samples, biological samples helpdesk, support with data integration into NUKLEUS-LIMS, and the release of biological samples
Brief description: The RAPID REVIVE study is evaluating an antiviral treatment for patients with Post-COVID syndrome.
Role of NUM-MB: SOP manualsfor biological samples, training materials and training courses on biological samples, biological samples helpdesk, support with data integration into NUKLEUS-LIMS, release of biological samples
Brief description: The RAPID RELAPSE study is evaluating the efficacy of bupropion in the treatment of fatigue associated with Post-COVID syndrome.
Role of NUM-MB: SOP manualsfor biological samples, training materials and training courses on biological samples, biological samples helpdesk, support with data integration into NUKLEUS-LIMS, dispensing of biological samples
Brief description: The CanTEN study is investigating whether a shorter course of antifungal treatment for candidemia is just as effective and safe as the previously recommended 14-day course of treatment. To this end, patients at 25 university hospitals are being treated in a randomised, double-blind, placebo-controlled trial.
Role of NUM-MB: SOP manuals for biological samples, training materials and training courses on biological samples, biological samples helpdesk, support with data integration into NUKLEUS-LIMS, dispensing of biological samples
Brief description:
- Population-based platform (POP, COVIDOM+): A population-representative long-term cohort for the monitoring of post-COVID sequelae and comorbidities
- Cross-sectoral Platform (SÜP): National, multicentre cohort comprising COVID-19 patients and controls
- High Resolution Platform (HAP, Pa-COVID-19): Hospitalised COVID-19 patients for in-depth phenotyping and early prognosis
Role of NUM-MB: Support for the re-use of biological samples, the release of biological samples, and the release of data associated with biological samples